These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27273949)

  • 21. Characterization of clear cell renal cell carcinoma by gene expression profiling.
    Thibodeau BJ; Fulton M; Fortier LE; Geddes TJ; Pruetz BL; Ahmed S; Banes-Berceli A; Zhang PL; Wilson GD; Hafron J
    Urol Oncol; 2016 Apr; 34(4):168.e1-9. PubMed ID: 26670202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis.
    Yuan L; Chen L; Qian K; Wang G; Lu M; Qian G; Cao X; Jiang W; Xiao Y; Wang X
    Oncol Rep; 2018 Feb; 39(2):525-536. PubMed ID: 29207195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer.
    Bhalla S; Chaudhary K; Kumar R; Sehgal M; Kaur H; Sharma S; Raghava GP
    Sci Rep; 2017 Mar; 7():44997. PubMed ID: 28349958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
    Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
    Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.
    Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression analysis of NGAL and NGALR in clear cell renal cell carcinoma.
    Liu F; Li N; Yang W; Wang R; Yu J; Wang X
    Gene; 2018 Nov; 676():269-278. PubMed ID: 30138675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.
    Duns G; van den Berg A; van Dijk MC; van Duivenbode I; Giezen C; Kluiver J; van Goor H; Hofstra RM; van den Berg E; Kok K
    Genes Chromosomes Cancer; 2013 Feb; 52(2):165-73. PubMed ID: 23074016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma.
    Nientiedt M; Schmidt D; Kristiansen G; Müller SC; Ellinger J
    Eur Urol Focus; 2018 Mar; 4(2):260-266. PubMed ID: 28753785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
    Zhai W; Lu H; Dong S; Fang J; Yu Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related variations in gene expression patterns of renal cell carcinoma.
    Feulner L; Najafabadi HS; Tanguay S; Rak J; Riazalhosseini Y
    Urol Oncol; 2019 Feb; 37(2):166-175. PubMed ID: 30478010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
    Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.